Old Web
English
Sign In
Acemap
>
authorDetail
>
Klaus Kopka
Klaus Kopka
Heidelberg University
Prostate cancer
Chemistry
Medicine
Antigen
Biodistribution
5
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Initiierung klinischer Multicenter-Studien mit lokaler Radiotracer-Herstellung: Regulatorisches Umfeld und radiopharmazeutisch-organisatorische Aspekte
2019
Claus Zippel
Oliver Neels
Ute Hennrich
Frederik L. Giesel
Klaus Kopka
Show All
Source
Cite
Save
Citations (4)
Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties
2017
Bioconjugate Chemistry
Ann-Christin Baranski
Martin Schäfer
Ulrike Bauder-Wüst
Anja Wacker
Jana Schmidt
Christos Liolios
Walter Mier
Uwe Haberkorn
Michael Eisenhut
Klaus Kopka
Matthias Eder
Show All
Source
Cite
Save
Citations (25)
Procedures for the GMP-Compliant Production and Quality Control of [ 18 F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer
2017
Oliver Neels
René Martin
Jens Cardinale
René Smits
Martin Schäfer
Alexander Hoepping
Marco Müller
Klaus Kopka
Show All
Source
Cite
Save
Citations (0)
Development of Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for PET Imaging of Prostate Cancer
2015
Christos Liolios
Martin Schäfer
Uwe Haberkorn
Matthias Eder
Klaus Kopka
Show All
Source
Cite
Save
Citations (0)
I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
2014
Christian M. Zechmann
Ali Afshar-Oromieh
Tom Armor
James B. Stubbs
Walter Mier
Boris Hadaschik
John Joyal
Klaus Kopka
Jürgen Debus
John W. Babich
Uwe Haberkorn
Show All
Source
Cite
Save
Citations (10)
1